Trial · NCT04704869
Outcomes19
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 19 of 19
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Mortality From Any Cause | 28 days after emergency department (ED) admission | Vital status was not available from any source for 34 in the Massive Transfusion Protocol arm and 39 in the Early Cryoprecipitate plus Massive Transfusion Protocol arm. Data presented are from an intention to treat analysis. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | All Cause Mortality at 6 Hours | 6 hours after ED admission | Data were not collected for 15 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected for 10 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | All Cause Mortality at 24 Hours | 24 hours after ED admission | Data were not collected for 16 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected for 11 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | All Cause Mortality at 6 Months | 6 months after ED admission | percentage of participants | NUMBER | |
| SECONDARY | All Cause Mortality at 12 Months | 12 months after ED admission | percentage of participants | NUMBER | |
| SECONDARY | Death From Bleeding at 6 Hours | 6 hours after ED admission | Data were not collected from 10 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected from 15 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Death From Bleeding at 24 Hours | 24 hours after ED admission | Data were not collected from 11 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected from 16 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Transfusion Requirements (Number of Units of Red Blood Cells (RBCs)) | from time of pre-hospital care to 24 hours after ED admission, an average of 30 hours | Data were not collected from 108 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected from 104 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | Units | MEDIAN |
| SECONDARY | Transfusion Requirements (Number of Units of Plasma) | from time of pre-hospital care to 24 hours after ED admission, an average of 30 hours | Data were not collected from 108 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected from 104 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | units | MEDIAN |
| SECONDARY | Transfusion Requirements (Number of Units of Platelets) | from time of pre-hospital care to 24 hours after ED admission, an average of 30 hours | Data were not collected from 110 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected from 104 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | Units | MEDIAN |
| SECONDARY | Transfusion Requirements (Number of Units of Cryoprecipitate) | from time of pre-hospital care to 24 hours after ED admission, an average of 30 hours | Data were not collected from 110 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected from 104 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | Units | MEDIAN |
| SECONDARY | Destination of Participant at Time of Discharge From Hospital | at the time of discharge from hospital, about 11-27 days after admission | Data were not collected from 431 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected from 424 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Quality of Life as Assessed by EuroQol-5 Dimension-5 Level (EQ5D-5L) | Day of hospital discharge or 28 days after ED admission (whichever comes first) | Data were not collected from 458 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected from 475 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | score on a scale | MEDIAN |
| SECONDARY | Quality of Life as Assessed by the Glasgow Outcome Score | Day of hospital discharge or 28 days after ED admission (whichever comes first) | Data were not collected from 93 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected from 94 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Quality of Life as Assessed by EuroQol-5 Dimension-5 Level (EQ5D-5L) | 6 months after ED admission | Data were not collected from 350 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected from 331 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | score on a scale | MEDIAN |
| SECONDARY | Quality of Life as Assessed by the Glasgow Outcome Score | 6 months after ED admission | Data for this outcome measure were not collected because the survey was not included on the 6-month follow-up. As a result, no participants received the survey, and therefore, no participants were analyzed in either study arm. | ||
| SECONDARY | Hospital Resource Use as Assessed by Number of Ventilator Days | Day of hospital discharge or 28 days after ED admission (whichever comes first) | Data were not collected from 34 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected from 36 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | days | MEDIAN |
| SECONDARY | Hospital Resource Use as Assessed by Number of Intensive Care Unit (ICU) Days | Day of hospital discharge or 28 days after ED admission (whichever comes first) | Data were not collected from 34 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected from 36 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | days | MEDIAN |
| SECONDARY | Hospital Resource Use as Assessed by Number of Hospital Days | Day of hospital discharge or 28 days after ED admission (whichever comes first) | Data were not collected from 33 participants in the Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. Data were not collected from 36 participants in the Early Cryoprecipitate + Massive Transfusion Protocol (RBCs, Plasma, Platelets, Whole Blood) arm. | days | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04704869/outcomes